Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C H Pui

Showing results (281-290 of 414) with videos related to

Pageof 42
Sort By:
Medical and Pediatric Oncology|January 1, 1988
High-dose methotrexate improves clinical outcome in children with acute lymphoblastic leukemia: St. Jude Total Therapy Study XM Abromowitch, J Ochs, C H Pui, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1994
Clinical features and treatment outcome for children with CD30+ large-cell non-Hodgkin's lymphomaJ T Sandlund, C H Pui, V M Santana, et al.
The Journal of Clinical Investigation|November 1, 1994
Blast cell methotrexate-polyglutamate accumulation in vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic leukemiaT W Synold, M V Relling, J M Boyett, et al.
Leukemia|February 25, 2005
Development of a regional flow cytometry center for diagnosis of childhood leukemia in Central AmericaS C Howard, D Campana, E Coustan-Smith, et al.
Blood|May 1, 1985
Prognostic importance of blast cell DNA content in childhood acute lymphoblastic leukemiaA T Look, P K Roberson, D L Williams, et al.
Leukemia|October 17, 2003
Treatment by design in leukemia, a meeting report, Philadelphia, Pennsylvania, December 2002R A Larson, G Q Daley, C A Schiffer, et al.
Blood|December 24, 1998
Hyperdiploid acute lymphoblastic leukemia with 51 to 65 chromosomes: a distinct biological entity with a marked propensity to undergo apoptosisC Ito, M Kumagai, A Manabe, et al.
Blood|April 1, 1996
Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting ageF G Behm, S C Raimondi, J L Frestedt, et al.
Computer Methods and Programs in Biomedicine|August 1, 1993
Management of cytogenetic data in multi-center leukemia trialsJ J Shuster, A J Carroll, T A Look, et al.
Blood|June 1, 1986
Cytogenetic features and serum lactic dehydrogenase level predict a poor treatment outcome for children with pre-B-cell leukemiaC H Pui, D L Williams, D K Kalwinsky, et al.
Pageof 42

Showing results (281-290 of 414) with videos related to

Sort By:
Pageof 42
Medical and Pediatric Oncology|January 1, 1988
High-dose methotrexate improves clinical outcome in children with acute lymphoblastic leukemia: St. Jude Total Therapy Study XM Abromowitch, J Ochs, C H Pui, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1994
Clinical features and treatment outcome for children with CD30+ large-cell non-Hodgkin's lymphomaJ T Sandlund, C H Pui, V M Santana, et al.
The Journal of Clinical Investigation|November 1, 1994
Blast cell methotrexate-polyglutamate accumulation in vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic leukemiaT W Synold, M V Relling, J M Boyett, et al.
Leukemia|February 25, 2005
Development of a regional flow cytometry center for diagnosis of childhood leukemia in Central AmericaS C Howard, D Campana, E Coustan-Smith, et al.
Blood|May 1, 1985
Prognostic importance of blast cell DNA content in childhood acute lymphoblastic leukemiaA T Look, P K Roberson, D L Williams, et al.
Leukemia|October 17, 2003
Treatment by design in leukemia, a meeting report, Philadelphia, Pennsylvania, December 2002R A Larson, G Q Daley, C A Schiffer, et al.
Blood|December 24, 1998
Hyperdiploid acute lymphoblastic leukemia with 51 to 65 chromosomes: a distinct biological entity with a marked propensity to undergo apoptosisC Ito, M Kumagai, A Manabe, et al.
Blood|April 1, 1996
Rearrangement of the MLL gene confers a poor prognosis in childhood acute lymphoblastic leukemia, regardless of presenting ageF G Behm, S C Raimondi, J L Frestedt, et al.
Computer Methods and Programs in Biomedicine|August 1, 1993
Management of cytogenetic data in multi-center leukemia trialsJ J Shuster, A J Carroll, T A Look, et al.
Blood|June 1, 1986
Cytogenetic features and serum lactic dehydrogenase level predict a poor treatment outcome for children with pre-B-cell leukemiaC H Pui, D L Williams, D K Kalwinsky, et al.
Pageof 42